News
CHICAGO, May 15, 2025--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused ... trial was accepted for poster presentation at the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback